SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2015 on Monday, February 29, 2016, before the U.S. financial markets open. ACADIA’s management will host a conference call and webcast on Monday, February 29, 2016, at 8:00 a.m. Eastern Time to discuss ACADIA’s financial results and operations.
